Haemoglobin adducts as biomarkers of exposure to tobacco-related nitrosamines

References

• Acosta M, Buchhalter A, Breland A, Hamilton D, Eissenberg T. Urine cotinine as an index of smoking status in smokers during 96-hr abstinence: comparison between gas chromatography/mass spectrometry and immunoassay test strips. Nicotine & Tobacco Research 2004; 64: 615–620
   Google Scholar
• Airoldi L, Vineis P, Colombi A, Olgiati L, Dell'Osta C, Fanelli R, Manzi L, Veglia F, Autrup H, Dunning A, et al. 4-Aminobiphenyl-hemoglobin adducts and risk of smoking-related disease in never smokers and former smokers in the European Prospective Investigation into Cancer and Nutrition prospective study. Cancer Epidemiology, Biomarkers & Prevention 2005; 149: 2118–2124
   Google Scholar
• Akiyama Y, Arashidani K, Kawano W, Kunugita N. Urinary nicotine and its metabolites as a biomarker of exposure to environmental tobacco smoke. J UOEH 2006; 283: 245–252
   Google Scholar
• Angerer J, Ewers U, Wilhelm M. Human biomonitoring: state of the art. International Journal of Hygiene and Environmental Health 2007; 2103-4: 201–228
   Google Scholar
• Atawodi SE, Lea S, Nyberg F, Mukeria A, Constantinescu V, Ahrens W, Brueske-Hohlfeld I, Fortes C, Boffetta P, Friesen MD. 4-Hydroxy-1-3-pyridyl-1-butanone-hemoglobin adducts as biomarkers of exposure to tobacco smoke: validation of a method to be used in multicenter studies. Cancer Epidemiology, Biomarkers & Prevention 1998; 79: 817–821
   Google Scholar
• Bader M, Lehnert G, Angerer J. GC/MS determination of N-phenylvaline, a possible biomarker for benzene exposure in human hemoglobin by the N-alkyl Edman method. International Archives of Occupational and Environmental Health 1994; 656: 411–414
   Google Scholar
• Bartsch H, Caporaso N, Coda M, Kadlubar F, Malaveille C, Skipper P, Talaska G, Tannenbaum SR, Vineis P. Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers. Journal of the National Cancer Institute 1990; 8223: 1826–1831
   Google Scholar
• Bernert JT, Jain RB, Pirkle JL, Wang L, Miller BB, Sampson EJ. Urinary tobacco-specific nitrosamines and 4-aminobiphenyl hemoglobin adducts measured in smokers of either regular or light cigarettes. Nicotine & Tobacco Research 2005; 75: 729–738
   Google Scholar
• Bryan SM, Hindmarsh PC. Normal and abnormal fetal growth. Hormone Research 2006; 65(Suppl. 3)19–27
   PubMedGoogle Scholar
• Chiolero A, Bovet P, Paccaud F. Association between maternal smoking and low birth weight in Switzerland: the EDEN study. Swiss Medical Weekly 2005; 13535-36: 525–530
   Google Scholar
• Dukic VM, Niessner M, Benowitz N, Hans S, Wakschlag L. Modeling the relationship of cotinine and self-reported measures of maternal smoking during pregnancy: a deterministic approach. Nicotine & Tobacco Research 2007; 94: 453–465
   Google Scholar
• Ehrenberg L, Granath F, Tornqvist M. Macromolecule adducts as biomarkers of exposure to environmental mutagens in human populations. Environmental Health Perspectives 1996; 104(Suppl. 3)423–428
   PubMedGoogle Scholar
• Ehrenberg L, Tornqvist M. 1992. Use of biomarkers in epidemiology: quantitative aspects. Toxicology Letters 64-65(Spec no):485–492.
   Google Scholar
• Falter B, Kutzer C, Richter E. Biomonitoring of hemoglobin adducts: aromatic amines and tobacco-specific nitrosamines. Clinical Investigations 1994; 725: 364–371
   Google Scholar
• Hammoud AO, Bujold E, Sorokin Y, Schild C, Krapp M, Baumann P. 2005. Smoking in pregnancy revisited: findings from a large population-based study. American Journal of Obstetrics & Gynecology 1926:1856-1862; discussion 1862–1853.
   Google Scholar
• Haufroid V, Lison D. Urinary cotinine as a tobacco-smoke exposure index: a minireview. International Archives of Occupational and Environmental Health 1998; 713: 162–168
   Google Scholar
• Haustein KO. Cigarette smoking, nicotine and pregnancy. International Journal of Clinical Pharmacology and Therapeutics 1999; 379: 417–427
   Google Scholar
• Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nature Reviews. Cancer 2003; 310: 733–744
   Google Scholar
• Hecht SS, Carmella SG, Murphy SE. Hemoglobin adducts as biomarkers of exposure to and metabolic activation of carcinogenic tobacco-specific nitrosamines. Biomedical and Environmental Sciences 1991; 41-2: 93–103
   Google Scholar
• Hoffmann D, Brunnemann KD, Prokopczyk B, Djordjevic MV. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. Journal of Toxicology and Environmental Health 1994; 411: 1–52
   Google Scholar
• Hoffmann D, Rivenson A, Chung FL, Hecht SS. Nicotine-derived N-nitrosamines TSNA and their relevance in tobacco carcinogenesis. Critical Reviews in Toxicology 1991; 214: 305–311
   Google Scholar
• Ingvarsson RF, Bjarnason AO, Dagbjartsson A, Hardardottir H, Haraldsson A, Thorkelsson T. The effects of smoking in pregnancy on factors influencing fetal growth. Acta Paediatrica 2007; 963: 383–386
   Google Scholar
• Joseph AM, Hecht SS, Murphy SE, Carmella SG, Le CT, Zhang Y, Han S, Hatsukami DK. Relationships between cigarette consumption and biomarkers of tobacco toxin exposure. Cancer Epidemiology, Biomarkers & Prevention 2005; 1412: 2963–2968
   Google Scholar
• LaVoie EJ, Stern SL, Choi CI, Reinhardt J, Adams JD. Transfer of the tobacco-specific carcinogens N'-nitrosonornicotine and 4-methylnitrosamino-1-3-pyridyl-1-butanone and benzo[a]pyrene into the milk of lactating rats. Carcinogenesis 1987; 83: 433–437
   Google Scholar
• Mansi G, Raimondi F, Pichini S, Capasso L, Sarno M, Zuccaro P, Pacifici R, Garcia-Algar O, Romano A, Paludetto R. Neonatal urinary cotinine correlates with behavioral alterations in newborns prenatally exposed to tobacco smoke. Pediatric Research 2007; 612: 257–261
   Google Scholar
• Matt GE, Quintana PJ, Liles S, Hovell MF, Zakarian JM, Jacob P 3rd, Benowitz NL. 2006. Evaluation of urinary trans-3'-hydroxycotinine as a biomarker of children's environmental tobacco smoke exposure. Biomarkers 116:507–523.
   PubMed Web of Science ®Google Scholar
• Nelson E, Goubet-Wiemers C, Guo Y, Jodscheit K. Maternal passive smoking during pregnancy and foetal developmental toxicity. Part 2: histological changes. Human & Experimental Toxicology 1999; 184: 257–264
   Google Scholar
• Nelson E, Jodscheit K, Guo Y. Maternal passive smoking during pregnancy and fetal developmental toxicity. Part 1: gross morphological effects. Human & Experimental Toxicology 1999; 184: 252–256
   Google Scholar
• Obed S, Patience A. Birth weight and ponderal index in pre-eclampsia: a comparative study. Ghana Medical Journal 2006; 401: 8–13
   Google Scholar
• Ogawa M, Oyama T, Isse T, Yamaguchi T, Murakami T, Endo Y, Kawamoto T. Hemoglobin adducts as a marker of exposure to chemical substances, especially PRTR class I designated chemical substances. Journal of Occupational Health 2006; 485: 314–328
   Google Scholar
• Okoli CT, Kelly T, Hahn EJ. Secondhand smoke and nicotine exposure: A brief review. Addictive Behavior 2007; 32: 1977–1988
   PubMed Web of Science ®Google Scholar
• Osterman-Golkar S, Bond JA. Biomonitoring of 1,3-butadiene and related compounds. Environmental Health Perspective 1996; 104(Suppl. 5)907–915
   PubMedGoogle Scholar
• Reckzeh G, Dontewill W, Leuschner F. Testing of cigarette smoke inhalation for teratogenicity in rats. Toxicology 1975; 43: 289–295
   Google Scholar
• Richter E, Branner B. Biomonitoring of exposure to aromatic amines: haemoglobin adducts in humans. Journal of Chromatography. B. Analytical Technologies in the Biomedical and Life Sciences 2002; 7781-2: 49–62
   Google Scholar
• Rodriguez JW, Kirlin WG, Wirsiy YG, Matheravidathu S, Hodge TW, Urso P. Maternal exposure to benzo[a]pyrene alters development of T lymphocytes in offspring. Immunopharmacology and Immunotoxicology 1999; 212: 379–396
   Google Scholar
• Sabbioni G, Jones CR, Sepai O, Hirvonen A, Norppa H, Jarventaus H, Glatt H, Pomplun D, Yan H, Brooks LR, Warren SH, Demarini DM, Liu YY. Biomarkers of exposure, effect, and susceptibility in workers exposed to nitrotoluenes. Cancer Epidemiology, Biomarkers & Prevention 2006; 153: 559–566
   Google Scholar
• Sardas S, Karahalil B, Akyol D, Kukner S, Karakaya AE. The effect of smoking on sister chromatid exchange rate of newborn infants born to smoking mothers. Mutation Research 1995; 3414: 249–253
   Google Scholar
• Scherer G, Engl J, Urban M, Gilch G, Janket D, Riedel K. Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany. Regulatory Toxicology and Pharmacology 2007; 472: 171–183
   Google Scholar
• Scherer G, Frank S, Riedel K, Meger-Kossien I, Renner T. Biomonitoring of exposure to polycyclic aromatic hydrocarbons of nonoccupationally exposed persons. Cancer Epidemiology, Biomarkers & Prevention 2000; 94: 373–380
   Google Scholar
• Smith CJ, Sears SB, Walker JC, DeLuca PO. 1992. Environmental tobacco smoke: current assessment and future directions. Toxicologic Pathology 202:289–303; discussion 303–285.
   Google Scholar
• Sorensen M, Bisgaard H, Stage M, Loft S. Biomarkers of exposure to environmental tobacco smoke in infants. Biomarkers 2007; 121: 38–46
   Google Scholar
• Tannenbaum SR. Hemoglobin-carcinogen adducts as molecular biomarkers in epidemiology. Princess Takamatsu Symposia 1990; 21: 351–360
   PubMedGoogle Scholar
• Tulunay OE, Hecht SS, Carmella SG, Zhang Y, Lemmonds C, Murphy S, Hatsukami DK. Urinary metabolites of a tobacco-specific lung carcinogen in nonsmoking hospitality workers. Cancer Epidemiology, Biomarkers & Prevention 2005; 145: 1283–1286
   Google Scholar
• Wu KY, Chiang SY, Huang TH, Tseng YS, Chen YL, Kuo HW, Hsieh CL. Formation of N-2-hydroxyethylvaline in human hemoglobin-effect of lifestyle factors. Mutation Research 2004; 5591-2: 73–82
   Google Scholar